{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T05:27:39Z","timestamp":1698125259959},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1990,5,1]],"date-time":"1990-05-01T00:00:00Z","timestamp":641520000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1990,5]]},"DOI":"10.1007\/bf00177262","type":"journal-article","created":{"date-parts":[[2004,8,22]],"date-time":"2004-08-22T08:15:28Z","timestamp":1093162528000},"page":"207-210","source":"Crossref","is-referenced-by-count":4,"title":["Pirarubicin (4\u2032-o-tetrahydropyranil-adriamycin) for treatment of advanced breast cancer"],"prefix":"10.1007","volume":"8","author":[{"given":"Werner","family":"Scheithauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Samonigg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dieter","family":"Depisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Sch\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hubert","family":"Hausmaninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Wiegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Zielinsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"St\u00f6ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Haider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Preis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Werner","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berthold","family":"Greifenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00177262_CR1","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.7164\/antibiotics.32.1082","volume":"32","author":"H Umezawa","year":"1979","unstructured":"Umezawa H, Takahashi Y, Kinoshita M, Naganawa H, Masuda T, Ishizuka M, Tatsuta K, Takeuchi T: Tetrahydropyranil derivates of daunomycin and adriamycin. J Antibiot 32: 1082\u20131084, 1979","journal-title":"J Antibiot"},{"key":"BF00177262_CR2","first-page":"1462","volume":"42","author":"T Tsuruo","year":"1982","unstructured":"Tsuruo T, Iida H, Tsukagoshi S, Sakurai Y: 4\u2032-o-tetrahydropyraniladriamycin as a potent new antitumor agent. Cancer Res 42: 1462\u20131467, 1982","journal-title":"Cancer Res"},{"key":"BF00177262_CR3","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.7164\/antibiotics.32.1085","volume":"32","author":"D Dantchev","year":"1979","unstructured":"Dantchev D, Paintrand M, Hayat M, Bourut C, Mathe G: Low heart and skin toxicity of tetrahydropyranil derivative of adriamycin (THP-ADM) as observed by electron and light microscopy. J Antibiot 32: 1085\u20131086, 1979","journal-title":"J Antibiot"},{"key":"BF00177262_CR4","first-page":"805","volume":"10","author":"H Majiama","year":"1983","unstructured":"Majiama H: Preliminary phase II clinical study of 4\u2032-o-te-trahydropyranil doxorubicin (THP-ADM). Gan To Kagaku Ryoho 10: 805\u2013810, 1983","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF00177262_CR5","first-page":"138","volume":"11","author":"H Nakada","year":"1984","unstructured":"Nakada H, Ogawa M, Miyamato H, Inagaki J, Horikoshi N, Inoue K, Ikeda K, Usui N, Adachi K, Okada Y: Phase II study of 4\u2032-o-tetrahydropyranyladriamycin (THP-ADM). Gan To Kagaky Ryoho 11: 138\u2013142, 1984","journal-title":"Gan To Kagaky Ryoho"},{"key":"BF00177262_CR6","first-page":"118","volume":"12","author":"A Wakui","year":"1985","unstructured":"Wakui A, Yokoyama M, Konno K, Nakai Y, Sakano T, Koyama Y, Imamura Y, Nakajima O, Niijiima T, Akaza H, Kimura I, Ohnoshi T, Hiraki S, Kato T, Nishimura H, Umezu J, Saito T: Phase I trial of 4\u2032-o-tetrahydropyranil doxorubicin (THP), a multi-institutional cooperative study. Gan To Kagaku Ryoho 12: 118\u2013124, 1985","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF00177262_CR7","first-page":"129","volume":"10","author":"M Ogawa","year":"1983","unstructured":"Ogawa M, Miyamoto H, Inagaki J, Horikoshi N, Ezaki K, Inoue K, Ikeda K, Usui N, Nakada H: Phase I clinic trial of a new anthracycline, 4\u2032-o-tetrahydropyranil-adriamycin. Gan To Kagaku Ryoho 10: 129\u2013133, 1983","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF00177262_CR8","first-page":"134","volume":"10","author":"H Majima","year":"1983","unstructured":"Majima H: Exploratory clinical study of 4\u2032-otetrahydropyranil doxorubicine (THP-ADM), Phase I. Gan To Kagaku Ryoho 10: 134\u2013140, 1983","journal-title":"Gan To Kagaku Ryoho"},{"key":"BF00177262_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00390491","volume":"114","author":"AA Miller","year":"1988","unstructured":"Miller AA, Scheulen ME, Kleeberg UR, Seeber S, Schmidt CG: Phase I study of pirarubicin. J Cancer Res Clin Oncol 114: 91\u201394, 1988","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF00177262_CR10","unstructured":"WHO Handbook for Reporting Results of Cancer Treatment, WHO offset publication No 48, Geneva, 1979"},{"key":"BF00177262_CR11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","volume":"53","author":"EL Kaplan","year":"1957","unstructured":"Kaplan EL, Meier B: Non-parametric estimation from incomplete observations, J Am Stat Assoc 53: 457\u2013481, 1957","journal-title":"J Am Stat Assoc"},{"key":"BF00177262_CR12","first-page":"101","volume":"2","author":"B Hoogstraten","year":"1979","unstructured":"Hoogstraten B, Fabian C: A reappraisal of single drugs in advanced breast cancer. Cancer Clin Trials 2: 101\u2013109, 1979","journal-title":"Cancer Clin Trials"},{"issue":"Suppl. B","key":"BF00177262_CR13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0305-7372(83)90021-X","volume":"10","author":"JA Neidhard","year":"1983","unstructured":"Neidhard JA, Gochnour D, Roach RW, Steinberg JA, Young D: Mitoxantrone versus doxorubicin in advanced breast cancer: a randomised cross-overtrial. Cancer Treat Rev 10 (Suppl. B): 41\u201346, 1983","journal-title":"Cancer Treat Rev"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00177262\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00177262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:17:34Z","timestamp":1678558654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00177262"}},"subtitle":["A clinical phase II study"],"short-title":[],"issued":{"date-parts":[[1990,5]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1990,5]]}},"alternative-id":["BF00177262"],"URL":"https:\/\/doi.org\/10.1007\/bf00177262","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,5]]}}}